Arabic Arabic English English French French German German
dark

Exavir Aims CRISPR Program at HIV, Sees Powerful Preclinical Results

Exavir Therapeutics announced that it was able to eliminate HIV from human cells with lipid nanoparticle (LNP)-delivered Tat-targeted CRISPR-Cas9.  Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Benefits of Flexible Packaging for Medical Devices Now Include Child Resistance

Next Post

Hummingbird Bioscience Announces Trials in Progress Poster Presentation at the Society for Immunotherapy of Cancer 2021 36th Annual Meeting

Related Posts
Total
0
Share